Repligen (RGEN) Earnings Date & Reports

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

RGEN is expected to report earnings to fall 5.60% to 45 cents per share on August 04

Q2'26

Est.

$0.45

Q1'26

Beat

by $0.10

Q4'25

Beat

by $0.05

Q3'25

Beat

by $0.04

Q2'25

Missed

by $0.02

The last earnings report on May 05 showed earnings per share of 47 cents, beating the estimate of 37 cents. With 693.73K shares outstanding, the current market capitalization sits at 6.90B.

View a ticker or compare two or three

Compare

RGEN

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for RGEN